Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Costco Wholesale Corporation (COST) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance

Costco Wholesale CorporationTrade
ImmunityBio Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Costco Wholesale Corporation vs ImmunityBio Inc. Common Stock — how do they compare? Costco Wholesale Corporation trades at $942.04 (market cap $417.54B), while ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B). The key difference: Costco Wholesale Corporation is far larger — about 40.4× ImmunityBio Inc. Common Stock's market cap, and Costco Wholesale Corporation pays a 0.62% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Costco Wholesale Corporation for 132 Days and ImmunityBio Inc. Common Stock for 0 Days on average.

COSTIBRX
Market Cap
$417.54B$10.33B
Volume
1,767,36211,745,198
Sector
Consumer StaplesHealth
52-Week High
$1.09K$11.55
52-Week Low
$849.63$1.98
Typical Hold Time
132 Days0 Days
Enterprise Value
$404.81B$10.79B
Dividend Yield
0.62%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Costco Wholesale Corporation

Costco (COST) trades at $947.92, up 1.31% with strong technical momentum and bullish moving averages. The company demonstrates consistent revenue growth, reaching $275.24B in 2025, with net income of $8.10B and robust cash flow generation. Recent March sales surged 11.3% year-over-year, while analyst consensus remains strongly bullish with a $1,090 price target. The stock trades near resistance at $947 with RSI levels indicating potential overbought conditions.

Costco's membership fee increase and expanding warehouse network support long-term growth, though elevated valuation metrics (P/E 45.39) present near-term risk. Strong institutional buying and 66% analyst buy ratings reflect confidence in the business model. Key risks include competitive pressures and macroeconomic sensitivity, but the company's defensive positioning and consistent execution provide stability.

ImmunityBio Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

COST
2% Buy98% Sell
Avg holding period · 132 Days
IBRX
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Costco Wholesale Corporation

The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet

Read more on COST →

About ImmunityBio Inc. Common Stock

ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.

Read more on IBRX →